Vuong Trieu, Chairman and CEO at Oncotelic Therapeutics, bought OTLC on Jun 17, 2026
Prices as of Oct 1 · price update delayed · Every feed →
- Traded
- Jun 17, 2026
- Disclosed
- Jun 17, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
OTLC since disclosure
−52.7%
Similar stocks (SPY) since disclosure
+3.1%
S&P 500 (SPY)
Change in closing price from Jun 17, 2026 (the first trading day on or after disclosure) to Oct 1, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▲ BUYVuong Trieu Chairman and CEOOTLC Oncotelic Therapeutics, Inc.$4.3Kdisclosed Jun 17 · filed 2 days after the trade